The Examination Of Cd47 And Its Potential Therapy Target Study On The Migration And Invasion In Non-Small Cell Lung Cancer

被引:0
|
作者
Wang, Q. [1 ]
Zhao, H. [1 ]
Wang, J. [1 ]
Du, X. [1 ]
Li, E. [1 ]
机构
[1] Dalian Med Univ, Hosp 2, Dalian, Peoples R China
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4608
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Unlocking the potential of CD70 as a therapeutic target in non-small cell lung cancer
    Jacobs, Julie
    Pauwels, Patrick
    Rolfo, Christian
    Lardon, Filip
    Deschoolmeester, Vanessa
    Deben, Christophe
    Van den Bossche, Jolien
    Zwaenepoel, Karen
    Hermans, Christophe
    Silence, Karen
    Thibault, Alain
    CANCER RESEARCH, 2015, 75
  • [22] CD47 receptor as a primary target for cancer therapy
    Ratnikova, N. M.
    Lezhnin, Y. N.
    Frolova, E. I.
    Kravchenko, J. E.
    Chumakov, S. P.
    MOLECULAR BIOLOGY, 2017, 51 (02) : 216 - 225
  • [23] CD47 receptor as a primary target for cancer therapy
    N. M. Ratnikova
    Y. N. Lezhnin
    E. I. Frolova
    J. E. Kravchenko
    S. P. Chumakov
    Molecular Biology, 2017, 51 : 216 - 225
  • [24] Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancer
    Cui, Zhilei
    Ruan, Zhengshang
    Zeng, Junxiang
    Sun, Jinyuan
    Ye, Wenjing
    Xu, Weiguo
    Guo, Xuejun
    Zhang, Linlin
    Song, Lin
    THORACIC CANCER, 2022, 13 (19) : 2723 - 2731
  • [25] HAGLROS is overexpressed and promotes non-small cell lung cancer migration and invasion
    Chen, Ying
    Shen, Tianle
    Ding, Xuping
    Cheng, Lei
    Sheng, Liming
    Du, Xianghui
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (09) : 1058 - 1067
  • [26] RBAK is upregulated in non-small cell lung cancer and promotes cell migration and invasion
    He, Bingjun
    Wang, Bin
    Wang, Haiyong
    Zhang, Chu
    Wu, Yuanlin
    Fu, Linhai
    Yu, Guangmao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (04) : 2942 - 2948
  • [27] Heat shock protein 47 promotes cell migration and invasion through AKT signal in non-small cell lung cancer
    Wu, Wei
    Hu, Zhenzhen
    Xiong, Linkai
    Zou, Juntao
    ANTI-CANCER DRUGS, 2022, 33 (03) : 268 - 277
  • [28] The potential of antiangiogenic therapy in non-small cell lung cancer
    Giaccone, Giuseppe
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1961 - 1970
  • [29] Ipilimumab: its potential in non-small cell lung cancer
    Tomasini, Pascale
    Khobta, Nataliya
    Greillier, Laurent
    Barlesi, Fabrice
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (02) : 43 - 50
  • [30] Androgen receptor as a potential target in non-small cell lung cancer
    Brennan, Sean
    Wang, Albert R.
    Beyer, Hope
    Wiese, Dylan
    Buehler, Darya
    Saeed, Anwaar
    Baschnagel, Andrew M.
    Iyer, Gopal
    CANCER RESEARCH, 2017, 77